Brexafemme

ibrexafungerp · Scynexis, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Brexafemme, covering 2024-07-03 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp [Phase 1]